Reporting owner · CIK 0002069137
Shao Wei-Li
SEC Form 4 history across 1 companies, 5 transactions and 4 filings.
PRESPresidentOmada Health, Inc.
Open-market transaction mix0% buys0 buys · 3 sales
Available history · Aug 12, 2026 – Sep 10, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
OMDAOmada Health, Inc. | Shao Wei-LiPRES | S · sale10b5-1 detectedSEC filing ↗ | -$9.01kView disclosure → | |
OMDAOmada Health, Inc. | Shao Wei-LiPRES | S · sale10b5-1 detectedSEC filing ↗ | -$79.1kView disclosure → | |
OMDAOmada Health, Inc. | Shao Wei-LiPRES | F · withholdingSEC filing ↗ | -$41.9kView disclosure → | |
OMDAOmada Health, Inc. | Shao Wei-LiPRES | S · sale10b5-1 detectedAmended filingSEC filing ↗ | -$235kView disclosure → | |
OMDAOmada Health, Inc. | Shao Wei-LiPRES | F · withholdingSEC filing ↗ | -$141kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Omada Health, Inc. on Sep 10, 2026 valued at $9,013.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 2 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Aug 2026 | 0 | 1 | $0.00 | $235,607.28 | -$235,607.28 |
| Sep 2026 | 0 | 2 | $0.00 | $88,206.17 | -$88,206.17 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$107.9K
Median P/S size$79.2K
Direct5
Indirect0
Sep 10, 2026sale
Filing-only signals
Deterministic matches in this insider's history
No filing-only signal badges matched this history.
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
5 observations · Aug 12, 2026 – Sep 10, 2026. Window ends at the latest available report, not today.
Selected observation · Sep 10, 2026295,313 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 12, 2026 | 307,372 | Sep 4, 2026 | Amended transaction |
| Sep 1, 2026 | 301,192 | Sep 3, 2026 | View transaction |
| Sep 5, 2026 | 299,349 | Sep 9, 2026 | View transaction |
| Sep 10, 2026 | 295,713 | Sep 14, 2026 | View transaction |
| Sep 10, 2026 | 295,313 | Sep 14, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Shao Wei-Li Insider Activity FAQ
SEC Form 4 context
Who is Shao Wei-Li?
Shao Wei-Li is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002069137.
Which companies has Shao Wei-Li reported transactions for?
Omada Health, Inc.
When was Shao Wei-Li's latest insider buy?
No open-market insider purchase is available for this period.
When was Shao Wei-Li's latest insider sale?
sale at Omada Health, Inc. on Sep 10, 2026 valued at $9,013.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.